Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

Female androgenic alopecia causes hair thinning in women, especially after menopause, and affects their mental well-being.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

The document concludes that hair loss is influenced by genetics and other factors, and while treatments like finasteride can help, they have limitations and side effects.

Nearly 70% of postmenopausal women in Saudi Arabia experience hair loss, often linked to early menopause, chronic diseases, family history, and stress.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Over-the-counter products can help with menopause symptoms, but be aware of their ingredients.

The laser system can safely improve recovery and quality of life for cervical cancer patients after surgery.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Estrogens can slow skin aging after menopause, but can't restore youthful skin.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Polycystic ovarian disease symptoms can continue after menopause, making diagnosis and management in older women challenging.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Combining hyaluronic acid and oxygen may help improve urinary incontinence in menopausal women.

Frontal fibrosing alopecia is a type of hair loss that usually happens after menopause.

Ovarian stromal tumors are a rare cause of women developing male characteristics after menopause.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Most women had adequate essential elements except zinc, and lead levels were higher in peri-/post-menopausal women.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Skin and hair aging involves mitochondrial issues, telomere shortening, and hormonal changes, with iron affecting hair loss in pre-menopausal women.

Age, sex, BMI, menopause, and specific genes affect hair density in East Asians.

Early postmenopausal women often experience skin issues like vaginal dryness, swallowing difficulties, hair loss, and uncommonly, keratoderma and hirsutism, but many are unaware these are related to menopause.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

Including androgens in hormone therapy may lower breast cancer risk.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.